Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Nonmelanomatous skin (squamous and basal cell)
Trial Type:  Prevention
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-18 of 18 for your search:
Start Over
Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood Arsenic
Phase: Phase IV
Type: Prevention
Status: Completed
Age: 20 to 65
Sponsor: NCI, Other
Protocol IDs: AAAC8618, R01CA133595, NCT01050556
Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer
Phase: Phase III
Type: Prevention
Status: Completed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067928, U01CA077158, WCCC-CO-9737, NCI-P00-0155, NCT00005884
Phase I/II Study of Chemopreventive Agents for the Prevention of Skin Cancer (Summary Last Modified 04/1999)
Phase: Phase II, Phase I
Type: Prevention
Status: Completed
Age: 50-84
Sponsor: NCI
Protocol IDs: MDA-ID-95184, NCI-P97-0099
Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer
Phase: Phase II
Type: Prevention
Status: Closed
Age: 15 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065820, BCM-H-109, NCI-P97-0105, NCT00003097
Phase II Trial of Fenretinide in Patients With Skin Actinic Keratosis (Summary Last Modified 05/98)
Phase: Phase II
Type: Prevention
Status: Closed
Age: 45 and over
Sponsor: NCI
Protocol IDs: MSGCC-9215, NCI-P97-0114
T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
Phase: Phase II
Type: Prevention
Status: Completed
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02619, UAB-0323, CDR0000378098, N01CN15136, NCT00089180
Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000581429, P30CA023074, P01CA027502, UARIZ-BIO-06182, 07-0032-04, BIO #06-182, NCT00601640
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068767, P01CA027502, UARIZ-HSC-0072, NCI-H01-0075, NCT00021294
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
Phase: Phase I
Type: Prevention, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE1Y04, P30CA043703, CASE-CWRU-1Y04, 10-03-01, CWRU-100301, CWRU1Y04, NCT00103246
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000522464, YALE-HIC-26866, N01-CN-25120, NCT00433485
Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers
Phase: Phase I
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000582627, P30CA023074, UARIZ-BIO-07-085, BIO-07-085, NCT00619060
Vitamin D Levels in the Skin of Healthy Subjects After Oral Supplementation
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI
Protocol IDs: NCI-2011-03469, CDR0000712963, 11-0270-04, UAZ10-16-03, N01CN35158, UARIZ-UAZ10-16-03, NCT01447355
Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066688, NCCTG-969251, NCI-P98-0137, NCT00003611
Study of Isotretinoin for Prevention of Skin Cancer in Patients With Xeroderma Pigmentosum (Summary Last Modified 11/2001)
Phase: No phase specified
Type: Prevention
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-84-C-39, NCI-T84-0256
Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000582327, P30CA015083, MC02C8, 1153-98, MAYO-MC02C8, NCT00644384
Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: SKIN0010, SU-10272011-8570, 22207, NCI-2012-00043, NCT01477463
Start Over